SLC2A4 and plasma cell myeloma: However, this GLUT4 cycling can also be overstimulated in case of various cancers, like plasma cell malignancy, multiple myeloma, etc. To treat such condition, several studies have been performed to develop GLUT4 antagonist synthetically [19,20].